TWD 91.2
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 115.73 Million TWD | 20.29% |
2022 | 96.21 Million TWD | -9.6% |
2021 | 106.42 Million TWD | -1.81% |
2020 | 108.38 Million TWD | 2.03% |
2019 | 106.22 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 125.51 Million TWD | 8.45% |
2024 Q2 | 125.51 Million TWD | 0.0% |
2023 Q3 | 115.73 Million TWD | 7.9% |
2023 Q4 | 115.73 Million TWD | 0.0% |
2023 FY | 115.73 Million TWD | 20.29% |
2023 Q2 | 107.26 Million TWD | 0.0% |
2023 Q1 | 107.26 Million TWD | 11.49% |
2022 Q3 | 96.21 Million TWD | 0.0% |
2022 Q4 | 96.21 Million TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Allied Biotech Corporation | 601.47 Million TWD | 80.758% |
GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | 25.54% |
Easywell Biomedicals, Inc. | 42.17 Million TWD | -174.445% |
TTY Biopharm Company Limited | 1.09 Billion TWD | 89.44% |
Synmosa Biopharma Corporation | 1.59 Billion TWD | 92.758% |
Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | 89.438% |
Center Laboratories, Inc. | 269.22 Million TWD | 57.012% |
Tien Liang BioTech Co., Ltd. | 75.79 Million TWD | -52.694% |
Orient Pharma Co., Ltd. | 233.97 Million TWD | 50.534% |
InnoPharmax Inc. | 22.24 Million TWD | -420.325% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 138.8 Million TWD | 16.621% |
Excelsior Biopharma Inc. | 217.28 Million TWD | 46.734% |
DV Biomed Co., Ltd. | 96.51 Million TWD | -19.915% |
Foresee Pharmaceuticals Co., Ltd. | 126.79 Million TWD | 8.725% |
Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
UniPharma Co., Ltd. | 28.94 Million TWD | -299.862% |
Anxo Pharmaceutical Co., Ltd. | 283.86 Million TWD | 59.228% |
Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
Mercury Biopharmaceutical Corporation | 10.07 Million TWD | -1048.858% |
Bioray Biotech Co., Ltd | 55.95 Million TWD | -106.856% |
TSH Biopharm Corporation Limited | 118.39 Million TWD | 2.246% |